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Electron microscopy of peripheral blood leucocytes to demonstrate excess glycogen was found to be a quick and useful aid to diagnosis. Histology of these adult cases showed a distribution of hepatocyte vacuolation which has not been previously recorded.
Type III glycogenosis is due to a deficiency of the debranching enzyme amylo 1-6 glucosidase which catalyses transfer of maltotriosyl residue from a side chain of glycogen to a main chain, leaving limit dextrin: the same enzyme then cleaves the solitary alpha 1-6 linked residue from the limit dextrin. The disease was first described by van Liver biopsy showed cirrhosis with regeneration nodules and fibrous septa (Fig. 1 ). There was some bile duct proliferation with a patchy infiltrate of lymphocytes and neutrophils in portal areas. Moderate centrilobular cholestasis was seen. Hepatocytes showed striking empty vacuolation which was only partly due to glycogen. This produced a mosaic pattern which was non-uniform, the larger most vacuolated cells being seen around portal areas and fibrous septa. There was striking massive nuclear vacuolation by glycogen as shown by diastase PAS.
A glucagon stimulation test with 1 mg intramuscular glucagon in the fasting state produced no rise in blood glucose but a 50 g galactose tolerance test showed a rise in blood glucose from 3 1 to 4 3 mmol/l.
The patient died four months after presentation with haematemesis from oesophageal varices. At necropsy his liver weighed 1450 g and showed an established cirrhosis. Liver glycogen content was 1 9 gCc (normal 1-5 g%) and skeletal muscle glycogen was 3-8 g% (normal less than 1 g%).5 The apparently normal liver glycogen was felt to be due to fibrous tissue "diluting" increased glycogen in remaining hepatocytes. Liver biopsy showed normal architecture with prominent empty vacuolation of the cytoplasm of hepatocytes. This was non-uniform across the lobules, being most striking in periportal areas, and virtually absent in centrilobular areas (Fig. 2) . This produced the "mosaic-like" pattern of cells described in type III glycogenosis.' There was also marked glycogen vacuolation of nuclei. No significant inflammatory component or fibrosis were seen in the biopsy.
A diagnosis of glycogen storage disease was supported by electron microscopy of leucocytes from a buffy layer. preparation of blood. These observations support those of previous studies.6 Glycogen appeared normal in lymphocytes and monocytes. There was excess of glycogen seen in neutrophil polymorphs. The excess of glycogen tended to be in coarser aggregates than in normal polymorphs and aggregated in the region of the smooth endoplasmic-reticulum (Fig. 3) . Neutrophils with a poorly segmented nucleus (younger cells) tended not to show this accumulation and differed little from cells taken from normal individuals. Most marked accumulations were seen in older cells with segmented nuclei and also in effete polymorphs. These findings were not present in cells from normal individuals.
Red cell glycogen content was 1006 p.g/g haemoglobin (normally less than 100 ug/g). Direct amylo 1-6 glucosidase assay on blood showed zero activity but phosphorylase was normal. In view of the Type III glycogenosis presenting as liver disease in adults with atypical histological features failure to induce fasting hypoglycaemia it was felt that the patient's fainting attacks were due to dumping secondary to his Polya gastrectomy.
Discussion
Although debranching enzyme was not assayed in the first case the patient clearly had type III glycogenosis because of history, biochemical, and histological findings. Glucagon failed to cause a rise in blood glucose in the fasting state because glycogen molecules cannot be degraded further than limit dextrin without the action of debranching enzyme.7 The normal blood glucose response to a galactose load excluded galactosaemia. Excess glycogen in skeletal muscle excluded type VI glycogenosis where hepatic phosphorylase is deficient.
In the second case the finding of striking empty vacuolation in hepatocytes prompted a search for excess leucocyte glycogen. Old or effete normal leucocytes show a loss of glycogen from the cytoplasm whereas in the patient's old leucocytes excess glycogen was seen. The determination of glycogen was of most diagnostic value when looking at older or effete cells and we confirmed this to be good supporting evidence of a glycogenosis, the diagnosis being confirmed by direct assay of the enzyme in blood leucocytes at a specialist centre. Electron microscopy of buffy coat leucocytes is a quick and easy procedure which is readily available in most laboratories. It can be used as a screening test to support a diagnosis of glycogenosis before sending blood for an enzyme assay.
The 
